Sporotrichosis - Revision history

Rossdonaldson1: /* Differential Diagnosis */

2022-06-07T20:18:10Z

Differential Diagnosis

← Older revision		Revision as of 20:18, 7 June 2022
Line 28:		Line 28:
	==Differential Diagnosis==		==Differential Diagnosis==
	{{SSTI DDX}}		{{SSTI DDX}}

	~~===Hand Infection===~~
	{{Hand Infection DDX}}		{{Hand Infection DDX}}

Rossdonaldson1: /* Clinical Features */

2022-06-07T20:17:26Z

Clinical Features

← Older revision		Revision as of 20:17, 7 June 2022
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==
	[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]		[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]
	[[File:PMC2729227 wjem-10-204f1.png\|thumb\| Lymphocutaneous sporotrichosis.]]		[[File:PMC2729227 wjem-10-204f1.png\|thumb\|Lymphocutaneous sporotrichosis.]]
	[[File:PMC4295339 DRP2014-272376.001.png\|thumb\|Lymphocutaneous sporotrichosis. Noduloulcerative lesions appear along the lymphatics proximal to the initial inoculation injury site.]]		[[File:PMC4295339 DRP2014-272376.001.png\|thumb\|Lymphocutaneous sporotrichosis. Noduloulcerative lesions appear along the lymphatics proximal to the initial inoculation injury site.]]
	''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''		''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''

Elcatracho: /* See Also */

2021-03-08T03:51:53Z

Rossdonaldson1: /* Workup */

2020-09-09T18:19:55Z

Workup

← Older revision		Revision as of 18:19, 9 September 2020
Line 32:		Line 32:
	{{Hand Infection DDX}}		{{Hand Infection DDX}}

	==~~Workup~~==		==Evaluation==
	*Fungal culture of skin, sputum, synovial fluid, or [[CSF]]		*Fungal culture of skin, sputum, synovial fluid, or [[CSF]]

Rossdonaldson1: /* Differential Diagnosis */

2020-09-09T18:19:25Z

Differential Diagnosis

← Older revision		Revision as of 18:19, 9 September 2020
Line 27:		Line 27:

	==Differential Diagnosis==		==Differential Diagnosis==
	~~===General===~~		{{SSTI DDX}}
	{{~~Template:~~SSTI DDX}}

	===Hand Infection===		===Hand Infection===
	{{~~Template:~~Hand Infection DDX}}		{{Hand Infection DDX}}

	==Workup==		==Workup==

Rossdonaldson1: /* Clinical Features */

2020-09-09T17:17:46Z

Clinical Features

← Older revision		Revision as of 17:17, 9 September 2020
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==
	[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]		[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]
			[[File:PMC2729227 wjem-10-204f1.png\|thumb\| Lymphocutaneous sporotrichosis.]]
	[[File:PMC4295339 DRP2014-272376.001.png\|thumb\|Lymphocutaneous sporotrichosis. Noduloulcerative lesions appear along the lymphatics proximal to the initial inoculation injury site.]]		[[File:PMC4295339 DRP2014-272376.001.png\|thumb\|Lymphocutaneous sporotrichosis. Noduloulcerative lesions appear along the lymphatics proximal to the initial inoculation injury site.]]
	''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''		''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''

Rossdonaldson1: /* Clinical Features */

2020-09-09T17:15:43Z

Clinical Features

← Older revision		Revision as of 17:15, 9 September 2020
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==
	[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]		[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]
			[[File:PMC4295339 DRP2014-272376.001.png\|thumb\|Lymphocutaneous sporotrichosis. Noduloulcerative lesions appear along the lymphatics proximal to the initial inoculation injury site.]]
	''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''		''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''
	===Forms and Symptoms===		===Forms and Symptoms===

Rossdonaldson1: /* Clinical Features */

2020-09-09T17:14:37Z

Clinical Features

← Older revision		Revision as of 17:14, 9 September 2020
Line 7:		Line 7:

	==Clinical Features==		==Clinical Features==
	Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus		[[File:PMC4295339 DRP2014-272376.002.png\|thumb\|Fixed cutaneous sporotrichosis. A crusted/verrucous plaque develops at inoculation site, seen here over face of a child.]]
			''Progresses slowly: first symptoms may appear 1 to 12 weeks (average 3 weeks) after the initial exposure to the fungus''
	===Forms and Symptoms===		===Forms and Symptoms===
	*''Cutaneous or skin''		*''Cutaneous or skin''

ClaireLewis at 01:38, 28 September 2019

2019-09-28T01:38:59Z

← Older revision		Revision as of 01:38, 28 September 2019
Line 1:		Line 1:
	==Background==		==Background==
	*Also known as "Rose gardener's disease"<ref>Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.</ref>		*Also known as "Rose gardener's disease"<ref>Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0.</ref>
	*Caused by the fungus ''Sporothrix schenckii''<ref>Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 654–6. ISBN 0-8385-8529-9.</ref> found on rose thorns		*Caused by the [[fungus]] ''[[Sporothrix schenckii]]''<ref>Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 654–6. ISBN 0-8385-8529-9.</ref> found on rose thorns
	*Usually affects skin, although other rare forms can affect the lungs, joints, bones, and brain		*Usually affects skin, although other rare forms can affect the lungs, joints, bones, and brain
	*Enters skin through small cuts and abrasions, and inhalation for pulmonary disease		*Enters skin through small cuts and abrasions, and inhalation for pulmonary disease
Line 12:		Line 12:
	*''Cutaneous or skin''		*''Cutaneous or skin''
	**Most common form		**Most common form
	**Symptoms include nodular lesions or bumps in the skin, at the point of entry and also along lymph nodes and vessels		**Symptoms include nodular [[rash\|lesions]] or bumps in the skin, at the point of entry and also along lymph nodes and vessels
	***Lesion starts off small and painless, and ranges in color from pink to purple		***Lesion starts off small and painless, and ranges in color from pink to purple
	***Left untreated, lesion becomes larger and looks similar to an [[abscess]]. More lesions will appear until a chronic ulcer develops		***Left untreated, lesion becomes larger and looks similar to an [[abscess]]. More lesions will appear until a chronic ulcer develops
Line 18:		Line 18:
	**Rare		**Rare
	**From inhalation of spores		**From inhalation of spores
	**Symptoms include productive ~~coughing~~, nodules and cavitations of the lungs, fibrosis, and hilar lymphadenopathy nodes		**Symptoms include productive [[cough]]ing, nodules and cavitations of the lungs, fibrosis, and hilar [[lymphadenopathy]] nodes
	**May become superinfected with pneumonia or tuberculosis		**May become superinfected with [[pneumonia]] or [[tuberculosis]]
	*''Disseminated sporotrichosis''		*''Disseminated sporotrichosis''
	**May affect joints and bones (osteoarticular sporotrichosis) and or CNS (''sporotrichosis meningitis'')		**May affect joints and bones (osteoarticular sporotrichosis) and or CNS (''sporotrichosis [[meningitis]]'')
	**Symptoms include weight loss, anorexia, and appearance of bony lesions		**Symptoms include weight loss, anorexia, and appearance of bony lesions

Line 32:		Line 32:

	==Workup==		==Workup==
	Fungal culture of skin, sputum, synovial fluid, or [[CSF]]		*Fungal culture of skin, sputum, synovial fluid, or [[CSF]]

	==Management==		==Management==
Line 43:		Line 43:
	***For disseminated of severe disease		***For disseminated of severe disease
	*Surgery		*Surgery
	**For [[osteomyelitis]] or ~~cavitatory~~ nodules in the lungs		**For [[osteomyelitis]] or cavitary nodules in the lungs
	*Standard antibiotics		*Standard [[antibiotics]]
	**Lesions sometimes become superinfected, consider as necessary		**Lesions sometimes become superinfected, consider as necessary

ClaireLewis: /* Management */

2016-07-15T23:57:18Z

Management

← Older revision		Revision as of 23:57, 15 July 2016
Line 36:		Line 36:
	==Management==		==Management==
	*Antifungal medication		*Antifungal medication
	**Itraconazole		**[[Itraconazole]]
	***Drug of choice (more effective than fluconazole)		***Drug of choice (more effective than fluconazole)
	**Fluconazole		**[[Fluconazole]]
	***Fluconazole (for patients who cannot tolerate itraconazole)		***Fluconazole (for patients who cannot tolerate itraconazole)
	**Amphotericin B IV		**[[Amphotericin B]] IV
	***For disseminated of severe disease		***For disseminated of severe disease
	*Surgery		*Surgery

← Older revision		Revision as of 03:51, 8 March 2021
Line 52:		Line 52:

	==See Also==		==See Also==
			*[[Fungal infections]]
			*[[Antifungals]]

	==References==		==References==